LIPOCINE INC. Current Liabilities
LIPOCINE INC. (LPCN) had Current Liabilities of $2.07 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-04
- 2026-06-30: Liabilities, Current $2.07M.
- 2026-03-31: Liabilities, Current $2.53M.
- 2025-12-31: Liabilities, Current $2.53M.
- 2025-09-30: Liabilities, Current $1.93M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $2.07M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $2.53M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $2.53M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $1.93M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $1.45M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $1.30M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $1.51M 10-K · filed 2026-03-10 | |
| 2024-09-30 | $1.58M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $1.82M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $1.49M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $2.63M 10-K · filed 2025-03-13 | |
| 2023-09-30 | $2.24M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $1.83M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $1.93M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $1.68M 10-K · filed 2024-03-07 | |
| 2022-09-30 | $1.51M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $1.71M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $3.52M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $5.62M 10-K · filed 2023-03-10 | |
| 2021-09-30 | $6.43M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $8.81M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $5.40M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $6.58M 10-K · filed 2022-03-09 | |
| 2020-09-30 | $5.79M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $4.23M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $4.06M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $4.96M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $5.23M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $4.44M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $4.28M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $4.49M 10-K · filed 2020-03-13 | |
| 2018-09-30 | $3.07M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $2.84M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $6.28M 10-Q · filed 2018-05-07 | |
| 2017-12-31 | $6.35M 10-K · filed 2019-03-06 | |
| 2017-09-30 | $2.48M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $2.90M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $2.34M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $1.33M 10-K · filed 2018-03-12 | |
| 2016-09-30 | $1.57M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $2.58M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $2.99M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $3.39M 10-K · filed 2017-03-06 | |
| 2015-09-30 | $2.18M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $1.67M 10-Q · filed 2015-08-11 | |
| 2015-03-31 | $1.34M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $1.63M 10-K · filed 2016-03-10 | |
| 2014-09-30 | $2.06M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $1.67M 10-Q · filed 2014-08-13 | |
| 2014-03-31 | $1.50M 10-Q · filed 2014-05-13 | |
| 2013-12-31 | $1.28M 10-K · filed 2015-03-11 | |
| 2013-09-30 | $1.63M 10-Q · filed 2013-11-13 | |
| 2013-06-30 | $17.64K 10-Q · filed 2013-07-09 | |
| 2013-03-31 | $14.99K 10-Q · filed 2013-04-24 | |
| 2012-12-31 | $212.81K 10-K · filed 2014-03-31 | $11.89K 10-K · filed 2013-02-26 |
| 2012-09-30 | $6.99K 10-Q · filed 2012-10-26 | |
| 2011-12-31 | $7.61K 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |